Evidence map›Paper›PMID 36026494›Full record

ArticlePloS one2022

Peer review: Risk and risk tolerance.

Stephen A Gallo, Karen B Schmaling

Abstract read
In one paragraph

Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Stephen A GalloScientific Peer Advisory and Review Services Division, American Institute of Biological Sciences, Herndon, Virginia, United States of America.ORCID 0000-0001-6043-2153
Karen B SchmalingDepartment of Psychology, Washington State University, Vancouver, Washington, United States of America.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Peer review, commonly used in grant funding decisions, relies on scientists' ability to evaluate research proposals' quality. Such judgments are sometimes beyond reviewers' discriminatory power and could lead to a reliance on subjective biases, including preferences for lower risk, incremental projects. However, peer reviewers' risk tolerance has not been well studied. We conducted a cross-sectional experiment of peer reviewers' evaluations of mock primary reviewers' comments in which the level and sources of risks and weaknesses were manipulated. Here we show that proposal risks more strongly predicted reviewers' scores than proposal strengths based on mock proposal evaluations. Risk tolerance was not predictive of scores but reviewer scoring leniency was predictive of overall and criteria scores. The evaluation of risks dominates reviewers' evaluation of research proposals and is a source of inter-reviewer variability. These results suggest that reviewer scoring variability may be attributed to the interpretation of proposal risks, and could benefit from intervention to improve the reliability of reviews. Additionally, the valuation of risk drives proposal evaluations and may reduce the chances that risky, but highly impactful science, is supported.

Indexed as

Financing, OrganizedPeer Review, ResearchCross-Sectional StudiesReproducibility of Results

Identifiers

PMID36026494
PMCPMC9417194

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.